Andes Hantavirus Quarantine in Nebraska: What This Rare Outbreak Reveals About Viral Transmission and Public Health Preparedness

Last updated: June 3, 2026. This is a rapidly evolving public health situation. All figures reflect the most recent verified data at time of publication. Readers should consult the CDC situation summary and WHO outbreak news for the latest updates.

On April 1, 2026, the Dutch expedition cruise ship MV Hondius departed from Ushuaia, Argentina, carrying 86 passengers and 61 crew members from 23 countries, bound for Antarctica and several remote South Atlantic islands. It was meant to be the trip of a lifetime. Within weeks, it had become one of the most internationally significant infectious disease events of 2026 - an outbreak of the rare, deadly, and uniquely dangerous Andes strain of hantavirus, unfolding in a sealed vessel on the open ocean.

By late May 2026, the MV Hondius outbreak had produced 10 confirmed cases and 2 suspected cases, with three deaths. Former passengers were hospitalized or under quarantine monitoring in Australia, Canada, France, Germany, the Netherlands, Singapore, South Africa, Spain, Switzerland, Turkey, and the United States.

At the center of the American response sits a facility most people have never heard of: the National Quarantine Unit at the University of Nebraska Medical Center in Omaha - the only federally funded quarantine unit of its kind in the United States, specifically designed to house and monitor individuals exposed to high-consequence infectious diseases. Eighteen people potentially exposed to hantavirus on the MV Hondius were repatriated to Nebraska for a 42-day monitoring period.

This outbreak raises questions that go far beyond one cruise ship. It reveals how rare pathogens travel in a globalized world, how public health systems must be structured to respond, and why the one feature that makes Andes virus uniquely dangerous among all known hantaviruses - its ability to spread from person to person - demands a level of containment and scientific understanding that the world is still working to build.

The MV Hondius Outbreak: A Timeline

The Incubation That Preceded Everything

Understanding this outbreak requires understanding how slowly and silently it began. Argentine officials told the Associated Press that the leading theory is that the index cases - a Dutch couple who became the first patients - contracted the virus during a bird-watching tour in Ushuaia before boarding. This would place the initial exposure in the rodent-rich terrain of southern Argentina, where Andes virus is endemic among the long-tailed pygmy rice rat (Oligoryzomys longicaudatus).

The MV Hondius set off on April 1. On April 6, the 70-year-old Dutch passenger fell ill with fever, headache, and diarrhea; he died on board April 11 after developing respiratory distress. His partner also became ill and died. On May 2, 2026, the WHO was notified of a cluster of severe acute respiratory illness aboard a cruise ship in the Atlantic Ocean, including two deaths and one critically ill passenger whose laboratory results confirmed hantavirus.

The weeks between initial exposures in late March and the May 2 WHO notification represent the most critical gap in this outbreak - a window during which cases were developing, person-to-person transmission may have been occurring, and no containment measures were in place.

The Ship Stranded: A Multi-Day Maritime Crisis

Although the ship docked at Praia, Cape Verde, for three days, no one disembarked, as local facilities were unable to handle a safe evacuation. After receiving approval from Spanish health authorities, the ship departed for Tenerife on May 6 with 147 individuals on board, arriving on May 10. Passengers disembarked and evacuation flights repatriated people to six European countries and Canada.

On May 7, CDC deployed a team to meet the ship in the Canary Islands, prepared to assess exposure risk among U.S. passengers and determine monitoring measures. By May 27, there were 13 confirmed and probable cases, including 3 deaths, with patients receiving care in France, South Africa, Switzerland, Singapore, and Spain.

WHO Director-General Tedros confirmed that all 11 reported cases were among passengers or crew on the ship, with nine confirmed as the Andes strain and two as probable.

The American Repatriation

In the U.S., 17 Americans and one British dual-national were monitored in medical facilities, with 16 at Nebraska Medicine. Among them was Dr. Stephen Kornfeld, an oncologist who had cared for ill passengers during the voyage. One repatriated passenger tested mildly PCR positive for the Andes strain, while another developed mild symptoms.

As of June 2, 2026 - the most recent update - five passengers left the quarantine facility and returned to their home states for the remainder of their monitoring. Thirteen people remain at the Nebraska Quarantine Unit.

What Makes Andes Virus Uniquely Dangerous

The Only Hantavirus That Spreads Between Humans

Of approximately 38 known hantavirus strains, virtually all follow the same pattern: rodent to human, through inhalation of aerosolized urine, feces, or saliva. Human-to-human transmission was first confirmed during a nosocomial hantavirus outbreak in 1996 in southern Argentina and appears to involve only the Andes strain. This is the only hantavirus, out of 38 known, capable of spreading person-to-person, although this mode remains marginal compared to rodent exposure.

Andes virus spread between people has typically required close, prolonged contact with a symptomatic person - including direct physical contact, prolonged time in enclosed spaces, and exposure to saliva, respiratory secretions, or other body fluids such as kissing, sharing utensils, or handling contaminated bedding.

This is what makes the confined environment of a cruise ship - with shared dining rooms, small cabins, and sustained close contact - so epidemiologically significant for a pathogen with this transmission profile.

The Biology: How Andes Virus Spreads Person-to-Person

Research in Frontiers in Microbiology found that Andes hantavirus infects and replicates in the lung alveolar epithelium, macrophages, and the secretory cells of the submandibular salivary glands - findings that support transmission through the respiratory and salivary pathways. This dual replication site explains why close respiratory contact and exposure to saliva are the primary routes of person-to-person spread.

Infection takes place during the early prodromal phase, and the incubation period ranges from 9 to 40 days - an extraordinarily wide window that is one of the most operationally challenging aspects of this outbreak.

Those repatriated to Nebraska are undergoing a 42-day monitoring period - a duration that deliberately encompasses the outer boundary of the known incubation range with a safety margin. The Andes strain is the only hantavirus known to spread person-to-person and can cause severe respiratory illness.

Clinical Severity: Hantavirus Pulmonary Syndrome

Once symptomatic, Andes virus infection follows the same clinical trajectory as other hantavirus pulmonary syndrome (HPS) cases. Initial symptoms - fever, headache, and muscle pain - are indistinguishable from dozens of common respiratory illnesses, routinely delaying diagnosis and allowing continued transmission.

The transition from prodrome to cardiopulmonary phase is rapid and frequently fatal. In severe cases, the virus triggers an immune response that floods the lungs with fluid, contributing to a mortality rate approaching 60% in hospitalized patients in parts of southern Chile. Among patients with severe respiratory symptoms, the case fatality rate has been estimated at approximately 38%.

There is currently no antiviral medication for hantavirus, and no vaccine exists. Treatment is entirely supportive medical care - making the window between symptom onset and hospital admission critically important.

The Long Incubation and the Challenge of Asymptomatic Cases

WHO has said they do not expect major updates to case figures due to the long incubation period of up to six weeks. Asymptomatic or mild infections make it difficult for public health systems to accurately estimate the true size of an outbreak, and reveal how little is known about viruses circulating in wild rodent populations before they reach humans.

Dr. Kornfeld's experience exemplifies this uncertainty. Before the outbreak was identified, several people on the MV Hondius developed a flu-like illness in early April. Kornfeld endured night sweats, chills, mild respiratory symptoms, and more than two weeks of severe fatigue - but at the time, there was no way to know if it was hantavirus.

This diagnostic ambiguity - where early Andes virus infection mimics common viral illness even to trained physicians - is one of the core surveillance challenges that any future outbreak response must address.

The Nebraska Quarantine Unit: America's Only Federal Containment Facility

What It Is and Why It Exists

The National Quarantine Unit (NQU) at UNMC's Global Center for Health Security is the only federally funded resource of its kind, designed to provide quarantine and isolation care for individuals exposed to highly hazardous communicable diseases. Its 20 rooms employ individual negative air pressure systems, are single occupancy with en suite bathroom facilities, and contain exercise equipment and WiFi for patients requiring longer stays.

The Training, Simulation, and Quarantine Center opened in October 2019, the result of a nearly $20 million grant from HHS's Administration for Strategic Preparedness and Response. It encompasses an entire floor of the $119 million Davis Global Center at UNMC's Omaha campus.

The NQU is distinct from the adjacent Nebraska Biocontainment Unit (NBU), which provides active clinical care for confirmed high-consequence infectious disease patients. The NBU team has prepared, trained, and drilled for over 18 years, caring for patients with viral hemorrhagic fevers like Ebola, Lassa fever, smallpox, and MERS. The unit treated three Ebola patients during the 2014 West African epidemic.

Why Nebraska Was Chosen for This Outbreak

UNMC was selected as the U.S. entry point due to its extensive expertise in handling special pathogens. It is one of 13 Regional Emerging Special Pathogen Treatment Centers within the National Special Pathogen System - purpose-built, drilled, and staffed for exactly this kind of response.

The facility's operational history also mattered. Nebraska previously housed Diamond Princess passengers during the early days of COVID-19 in 2020, giving it direct experience managing potentially exposed groups from maritime environments. Quarantine protocols, mental health support, extended stays, and daily medical monitoring had all been worked through in practice before the Hondius arrived.

Nebraska Medicine also worked in conjunction with CDC and public health labs to rapidly develop Andes-specific testing - a capability unavailable at most other U.S. facilities - providing turnaround times critical to monitoring decisions.

The Diagnostic Gap Exposed by This Outbreak

One of the most important lessons from this event is that Andes-specific testing was not routinely available at state laboratory level across the United States. The North Carolina State Laboratory of Public Health, for example, cannot currently test for the Andes strain - any suspected sample must be sent to the CDC for analysis.

This means that if an exposed individual had returned home to a state without specialized capacity and developed symptoms, the diagnostic delay would have required days of sample shipment time before a result could be obtained - days during which clinical management proceeds on suspicion alone. In a disease with a 30 to 40% case fatality rate among severely ill patients, that gap is life-or-death.

The 42-day centralized quarantine directly addressed this by keeping exposed individuals in a location where rapid Andes testing was immediately available throughout the entire incubation window.

What This Outbreak Reveals About Public Health Preparedness

Five Structural Lessons the MV Hondius Has Already Taught

1. Zoonotic spillover from wildlife tourism is a persistent and growing risk. The leading theory is that index cases contracted Andes virus during a bird-watching tour in Ushuaia before boarding. Wildlife ecotourism in rodent-diverse environments across South America, Southeast Asia, and sub-Saharan Africa creates consistent exposure interfaces between international travelers and zoonotic pathogens that the global health system has not fully mapped.

2. Maritime environments create unique amplification conditions. A cruise ship is an ideal environment for a close-contact pathogen: a sealed population in sustained close contact over weeks, with shared ventilation, dining, and social spaces. The MV Hondius outbreak's containment within the shipboard population reflected Andes virus's limited transmissibility; a more efficiently transmitted pathogen in the same environment would have produced a dramatically different outcome.

3. International coordination remains challenging - and is improving. National Focal Points of affected countries were in contact about passenger information through established IHR channels. The multi-country repatriation of passengers to quarantine facilities across 12 countries was accomplished without a major secondary transmission event - a real-world test of the post-COVID international health architecture.

4. The US withdrawal from WHO created measurable operational gaps. The outbreak occurred after the United States, one of the largest WHO supporters, officially withdrew its membership. Argentina - which has the most experience with Andes of any country - also withdrew earlier this year. CDC had not yet held any public briefings on the outbreak despite US passengers being on board. Institutional withdrawal from multilateral health governance creates information gaps at precisely the moments when coordination is most needed.

5. Diagnostic capacity must be distributed, not centralized. The Andes testing gap at the state laboratory level is a microcosm of a broader preparedness vulnerability: the U.S. system for diagnosing rare pathogens is heavily centralized at the CDC, with limited surge capacity at the regional level. Building distributed laboratory infrastructure before the next outbreak makes that capacity urgently necessary is the preparedness investment this response has made visibly urgent.

Is Andes Virus a Pandemic Threat?

The question accompanying virtually every news story about this outbreak is whether Andes virus could cause the next pandemic. WHO has emphasized that the risk of an epidemic is low, as previous outbreaks have only involved transmission in close-contact settings. The overall public risk is deemed low. Spread between humans is not common and requires close, prolonged contact with infected individuals.

The key biological distinction is transmission efficiency. SARS-CoV-2 achieved pandemic spread because a single infected person could infect 2 to 5 others in everyday community settings. Andes virus requires prolonged close contact with a symptomatic individual - between intimate partners, family caregivers, or healthcare workers without adequate PPE. This difference prevents the kind of exponential community spread that defines pandemic potential.

What Andes virus does represent is a serious risk to close contacts and healthcare workers - and the MV Hondius illustrated exactly the conditions under which human-to-human transmission is most likely to amplify.

The No-Vaccine, No-Treatment Gap

Like the Bundibugyo Ebola strain simultaneously causing an outbreak in Central and East Africa, Andes hantavirus has no licensed vaccine and no approved antiviral treatment. This absence of medical countermeasures means containment, early detection, and infection control are the only tools available to limit mortality - placing an enormous premium on rapid case identification and specialized clinical care.

Research into hantavirus vaccines and antivirals has been ongoing for decades, with several candidates in early development. The visibility of the MV Hondius outbreak and its multi-country impact may accelerate research investment and regulatory attention in a way that sporadic, geographically isolated previous outbreaks did not.

What Travelers, Clinicians, and the Public Need to Know

Current Risk to the General Public

The risk to the US public is considered extremely low. Andes virus is not endemic in North America - the Sin Nombre hantavirus, which circulates in North American rodent populations, causes HPS through rodent-to-human transmission only and does not spread person-to-person.

As of the latest CDC update, while 13 people remain at the NQU, five have returned home to complete their monitoring, and no community cases in the United States have been reported in connection with the ship.

For Travelers Planning Expeditions to South America and Antarctica

Andes virus is endemic in the rodent populations of southern South America - particularly in Argentina, Chile, and neighboring countries where Oligoryzomys longicaudatus is prevalent. Travelers engaging in outdoor activities in these regions should be aware of the following risk reduction measures:

• Avoid handling or approaching wild rodents or their nesting materials
• Do not enter or clean enclosed spaces that show evidence of rodent infestation without appropriate precautions
• Ventilate enclosed spaces before entering and wet-clean rather than dry-sweep surfaces to avoid aerosolizing rodent excreta
• Be aware that early symptoms - fever, fatigue, muscle pain, headache - appear 9 to 40 days after exposure and are clinically indistinguishable from influenza

For Healthcare Workers

Healthcare workers caring for suspected or confirmed Andes virus patients must use full airborne and contact precautions - including N95 respirators or higher, face shields, gowns, and gloves. Any patient presenting with severe respiratory illness and a travel history to southern South America within the past 40 days warrants hantavirus evaluation and immediate public health reporting.

The MV Hondius outbreak included at least one case of likely healthcare worker exposure on board - a pattern seen in previous Andes outbreaks and consistent with the pathogen's propensity for person-to-person transmission in close care settings.

The 42-Day Monitoring Rationale

The 42-day quarantine period at Nebraska - two days beyond the maximum 40-day incubation - reflects a deliberate safety margin. The additional two days ensure individuals exposed at the very end of their exposure window have fully cleared the incubation period before returning to their communities.

This period also allows serial testing to confirm that individuals who test negative during initial monitoring have not developed a rising antibody titer indicating recent infection. Ongoing monitoring of the MV Hondius cohort may ultimately help clarify whether the outer incubation boundary is longer in a subset of cases.

The Broader Context: A World Still Learning to Respond

The MV Hondius outbreak is the most visible and internationally impactful Andes hantavirus event in recorded history. It has simultaneously exposed both the strengths and vulnerabilities of the global public health infrastructure - demonstrating that specialized biocontainment facilities can function as intended, that international repatriation can be accomplished safely, and that the diagnostic and surveillance gaps identified after previous outbreaks remain only partially addressed.

The response has been operationally competent at the specialized facility level. The Global Center for Health Security at Nebraska is the premier U.S. institution for management of high-consequence infections and hazards. The 42-day quarantine, rapid Andes-specific testing, and multi-country repatriation without confirmed secondary community transmission all represent the system functioning as designed.

What the response has also revealed is the fragility of that system when institutional foundations are weakened. The withdrawal of the United States and Argentina from the WHO - at the moment their expertise was most urgently needed for a pathogen endemic in one country and whose only advanced quarantine facility is in the other - is a case study in how geopolitical decisions produce infectious disease consequences.

The question the MV Hondius asks of the global health community is not whether we have the capability to respond to rare, dangerous pathogens in specialized settings. We do. The question is whether we will maintain and fund the multilateral relationships, distributed diagnostic capacity, and early warning systems that give those specialized capabilities the information they need to act before outbreaks become crises.

This article is for informational purposes only. If you are experiencing a medical emergency, contact local emergency services immediately. For the most current outbreak data, consult the CDC situation summary and WHO outbreak news.